SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-22-244850
Filing Date
2022-09-14
Accepted
2022-09-14 17:31:04
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFM14A d359803ddefm14a.htm DEFM14A 1429633
2 GRAPHIC g359803g00v66.jpg GRAPHIC 27297
3 GRAPHIC g359803g04p02.jpg GRAPHIC 63777
4 GRAPHIC g359803g08a23.jpg GRAPHIC 24953
5 GRAPHIC g359803g19p37.jpg GRAPHIC 57349
6 GRAPHIC g359803g37p88.jpg GRAPHIC 52759
7 GRAPHIC g359803g88p19.jpg GRAPHIC 52381
8 GRAPHIC g359803newwpc1.jpg GRAPHIC 220068
9 GRAPHIC g359803newwpc2.jpg GRAPHIC 342325
  Complete submission text file 0001193125-22-244850.txt   2582849
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-35420 | Film No.: 221243832
SIC: 2834 Pharmaceutical Preparations